Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: Analysis of 131 recipients and donors

Bone Marrow Transplantation

Volumn 45, Issue 1, 2010, Pages 13-19

  Neth, O W ^a,b   Bacher, U ^c   Das, P ^c   Zabelina, T ^c   Kabisch, H ^c,d   Kroeger, N ^c   Ayuk, F ^c   Lioznov, M ^c   Waschke, O ^c   Fehse, B ^c,e   Thiebaut R ^a,f   Haston, R M ^a   Klein, N ^a   Zander, A R ^c  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^f INSERM   (France)

Author keywords

Allo SCT; Infection; Mannan binding lectin protein; MBL variants; Sepsis

Indexed keywords

MANNOSE BINDING LECTIN; OLIGOMER;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; GENOTYPE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; IMMUNE STATUS; INFECTION SENSITIVITY; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; SEPSIS; VIRUS ACTIVATION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; DISEASE SUSCEPTIBILITY; FEMALE; GENOTYPE; GRAFT VS HOST DISEASE; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; MYCOSES; PHENOTYPE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEPSIS; STEM CELL TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 75149137431     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.90     Document Type: Article

References (28)

1. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-540.
2. Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002; 56: 630-641.
3. Sastry K, Herman GA, Day L, Deignan E, Bruns G, Morton CC et al.. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med 1989; 170: 1175-1189.
4. Smithson A, Munoz A, Suarez B, Soto SM, Perello R, Soriano A et al.. Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coli. Clin Vaccine Immunol 2007; 14: 256-261.
5. Garred P, Strom J, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003; 188: 1394-1403.
6. Vekemans M, Robinson J, Georgala A, Heymans C, Muanza F, Paesmans M et al.. Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. Clin Infect Dis 2007; 44: 1593-1601.
7. Schlapbach LJ, Aebi C, Otth M, Luethy AR, Leibundgut K, Hirt A et al.. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients. Pediatr Blood Cancer 2007; 49: 11-16.
8. Mullighan CG, Heatley SL, Danner S, Dean MM, Doherty K, Hahn U et al.. Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation. Blood 2008; 112: 2120-2128.
9. Molle I, Peterslund NA, Thiel S, Steffensen R. MBL2 polymorphism and risk of severe infections in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant 2006; 38: 555-560.
10. Mullighan CG, Bardy PG. Mannose-binding lectin and infection following allogeneic hemopoietic stem cell transplantation. Leuk Lymphoma 2004; 45: 247-256.
11. Manuel O, Pascual M, Trendelenburg M, Meylan PR. Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation. Transplantation 2007; 83: 359-362. (Pubitemid 46247871)
12. Granell M, Urbano-Ispizua A, Suarez B, Rovira M, Fernandez- Aviles F, Martinez C et al.. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Exp Hematol 2006; 34: 1435-1441.
13. Berger SP, Roos A, Mallat MJ, Fujita T, de Fijter JW, Daha MR. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant 2005; 5: 1361-1366.
14. Jack D, Bidwell J, Turner M, Wood N. Simultaneous genotyping for all three known structural mutations in the human mannose-binding lectin gene. Hum Mutat 1997; 9: 41-46.
15. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP et al.. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155: 3013-3020.
16. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 1995; 85: 660-667.
17. Fiegel HC, Lioznov MV, Cortes-Dericks L, Lange C, Kluth D, Fehse B et al.. Liver-specific gene expression in cultured human hematopoietic stem cells. Stem Cells 2003; 21: 98-104. (Pubitemid 36120370)
18. Kibbler C. Defining invasive fungal infections in neutropenic or stem cell transplant patients. J Antimicrob Chemother 2005; 56 (Suppl 1): i12-i16.
19. Mullighan CG, Heatley S, Doherty K, Szabo F, Grigg A, Hughes TP et al.. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99: 3524-3529.
20. Kilpatrick DC, Stewart K, Allan EK, McLintock LA, Holyoake TL, Turner ML. Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency. Bone Marrow Transplant 2005; 35: 179-181.
21. Bouwman LH, Roos A, Terpstra OT, De KP, van HB, Verspaget HW et al.. Mannose binding lectin gene polymorph- isms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005; 129: 408-414.
22. Rocha V, Franco RF, Porcher R, Bittencourt H, Silva Jr WA, Latouche A et al.. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLAidentical sibling bone marrow transplantation. Blood 2002; 100: 3908-3918.
23. IP WK, Lau YL. Role of mannose-binding lectin in the innate defense against Candida albicans: enhancement of complement activation, but lack of opsonic function, in phagocytosis by human dendritic cells. J Infect Dis 2004; 190: 632-640.
24. Turner MW, Johnson M, Booth C, Klein N, Rolland J, Davies J. Assays for human mannose-binding lectin. J Immunol Methods 2003; 276: 147-149.
25. Neth O, Jack DL, Johnson M, Klein NJ, Turner MW. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannosebinding lectin-associated serine protease after binding to Staphylococcus aureus. J Immunol 2002; 169: 4430-4436.
26. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 2001; 184: 1152-1162.
27. Moller-Kristensen M, Ip WK, Shi L, Gowda LD, Hamblin MR, Thiel S et al.. Deficiency of mannose-binding lectin greatly increases susceptibility to post burn infection with Pseudomonas aeruginosa. J Immunol 2006; 176: 1769-1775.
28. Allen ML, Peters MJ, Goldman A, Elliott M, James I, Callard R et al.. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 2002; 30: 1140-1145.